Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Multi-Target Hybrid Drugs: A Promising Approach for Treating Alzheimer's, Neurological Diseases, Diabetes, and Cancer Publisher



Lalani AR1 ; Ebrahimbabaie F2 ; Sojoudi M3 ; Pouyani NR4 ; Sharifabad MS5 ; Fakhari F4 ; Rezaei S6
Authors

Source: Journal of Chemical Health Risks Published:2025


Abstract

Multi-target drugs are a class of hybrid compounds that can act on multiple targets and diseases simultaneously. These drugs have the potential to treat a range of disorders including Alzheimer's disease, diabetes, and cancer. This review aims to assess the efficacy of acridine-and tacrine-based multi-target hybrid drugs for the treatment of various diseases. In December 2022, a systematic literature search was conducted using acridine, tacrine, multi-target agent, and multi-factorial diseases along with their synonyms. According to the findings, acridine-based conjugates exhibited anti-cancer and anti-diabetic properties by directly inhibiting α-Glucosidase and α-Amylase, and by binding to DNA, topoisomerases, histone deacetylase, and poly (ADP-ribose) polymerase. The results suggest that acridine-and tacrine-based hybrid complexes have the potential to serve as promising multi-target agents for the treatment of Alzheimer's disease, neurological disorders, diabetes, and cancer. Overall, these compounds offer a new approach to drug development by targeting multiple disease pathways with a single agent. In conclusion, the use of multi-target drugs could potentially lead to improved therapeutic outcomes with fewer side effects, making them a promising area of research for the treatment of complex diseases. Keywords for this review include acridine, tacrine, multi-factorial diseases, and multi-target drugs. © 2025, Islamic Azad University. All rights reserved.
Related Docs
View other Related Docs
1. A Review on Tacrine-Based Scaffolds As Multi-Target Drugs (Mtdls) for Alzheimer's Disease, European Journal of Medicinal Chemistry (2017)
2. Design and Synthesis of Novel Anti-Alzheimer's Agents: Acridine-Chromenone and Quinoline-Chromenone Hybrids, Bioorganic Chemistry (2016)
3. Lipoic Acid Scaffold Applications in the Design of Multitarget-Directed Ligands Against Alzheimer's Disease, Bioorganic Chemistry (2025)
Experts (# of related papers)
View all Related Experts
Mohammad Mahdavi (12)
Mina Saeedi (7)
Other Related Docs
4. Novel Tacrine-1,2,3-Triazole Hybrids: In Vitro, in Vivo Biological Evaluation and Docking Study of Cholinesterase Inhibitors, European Journal of Medicinal Chemistry (2017)
5. New Imidazo[1,2-A]Pyridin-2-Yl Derivatives As Ache, Bche, and Lox Inhibitors; Design, Synthesis, and Biological Evaluation, Letters in Drug Design and Discovery (2023)
6. Synthesis and Evaluation of Novel Arylisoxazoles Linked to Tacrine Moiety: In Vitro and in Vivo Biological Activities Against Alzheimer’S Disease, Molecular Diversity (2022)
7. Thieno[2,3-B]Pyridine Amines: Synthesis and Evaluation of Tacrine Analogs Against Biological Activities Related to Alzheimer's Disease, Archiv der Pharmazie (2020)
8. Synthesis, Docking, Pharmacokinetic Prediction, and Acetylcholinesterase Inhibitory Evaluation of N-(2-(Piperidine-1-Yl)Ethyl)Benzamide Derivatives As Potential Anti-Alzheimer Agents, Research in Pharmaceutical Sciences (2024)
9. Synthesis of New 3-Arylcoumarins Bearing N-Benzyl Triazole Moiety: Dual Lipoxygenase and Butyrylcholinesterase Inhibitors With Anti-Amyloid Aggregation and Neuroprotective Properties Against Alzheimer’S Disease, Frontiers in Chemistry (2022)
10. Pyrano[2,3-B]Chromone Derivatives As Novel Dual Inhibitors of Α-Glucosidase and Α-Amylase: Design, Synthesis, Biological Evaluation, and in Silico Studies, Bioorganic Chemistry (2024)
11. Discovery of Imidazopyridines Containing Isoindoline-1,3-Dione Framework As a New Class of Bace1 Inhibitors: Design, Synthesis and Sar Analysis, European Journal of Medicinal Chemistry (2017)
12. The Effects of Photodynamic Therapy With Low-Level Diode Laser Compared With Doxorubicin on Ht-29 Colorectal Adenocarcinoma Cells Viability, Photobiomodulation, Photomedicine, and Laser Surgery (2025)
13. Novel Diazen-Bis(Phenoxy-1,2,3-Triazole-N-Phenylacetamide) Derivatives As Potent Anti-Cholinesterase, Anti-Α-Glycosidase and Anti-Α-Amylase Agents: In Vitro and in Silico Evaluations, Journal of Molecular Structure (2025)
14. Anticholinesterase Activities of Novel Isoindolin-1,3-Dione-Based Acetohydrazide Derivatives: Design, Synthesis, Biological Evaluation, Molecular Dynamic Study, BMC Chemistry (2024)
15. Combination Therapy in Alzheimer's Disease: Is It Time?, Journal of Alzheimer's Disease (2022)
16. Design, Synthesis and Biological Assessment of New 1-Benzyl-4-((4-Oxoquinazolin-3(4H)-Yl)Methyl) Pyridin-1-Ium Derivatives (Bops) As Potential Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase, Heliyon (2021)
17. Novel N-Benzylpiperidine Derivatives of 5-Arylisoxazole-3-Carboxamides As Anti-Alzheimer's Agents, Archiv der Pharmazie (2021)
18. Introduction of New Quinolone-2-Thio-Acetamide-Propane Hydrazide-Benzimidazole Derivatives As New Α-Glucosidase and Α-Amylase Inhibitors, Scientific Reports (2025)
19. Chromone–Lipoic Acid Conjugate: Neuroprotective Agent Having Acceptable Butyrylcholinesterase Inhibition, Antioxidant and Copper-Chelation Activities, DARU# Journal of Pharmaceutical Sciences (2021)
20. Synthesis, and in Vitro Biological Evaluations of Novel Naphthoquinone Conjugated to Aryl Triazole Acetamide Derivatives As Potential Anti-Alzheimer Agents, Journal of Molecular Structure (2022)